Investment Focus
HEST’s mainstay is an assertive yet responsible financial strategy. When it comes to investments, we strive to strike a delicate balance between ambition and sustainability.
Our attention is primarily driven towards Series B or pre-market rounds, where we can harness the potential of fledgling establishments, targeting substantial growth. Our overarching investment strategy welcomes all possibilities, offering a fertile ground for lucrative ideas to prosper.
VALERION
Valerion is developing ion-selective separator membranes to create safer, cheaper, and more energy-dense batteries. The adoption of electric mobility is hindered by high battery costs and strained raw material resources, while end-user expectations for better performance continue to rise.
Valerion’s next-generation battery components are designed to be safe and resilient, using materials found in bullet-proof vests, energy-dense for applications like aviation and trucking, and flexible and scalable across various uses.
Secretome Therapeutics is developing cell-based therapy designed for people who experience a heart attack and patients with advanced heart failure.
The therapy is developed from neonatal cardiac progenitor cells derived from tissue discarded during lifesaving heart surgery in babies with congenital heart conditions, enabling medical practitioners to treat patients suffering from heart failure and opening the door to endless possibilities for future therapies.
Claim Return LLC simplifies the process of claiming returns for individuals who have overpaid for services such as medical bills, property taxes, or insurance premiums.
Through their streamlined approach, clients can easily submit their information online, allowing Claim Return LLC to analyze their case and pursue a refund on their behalf. With a focus on transparency and efficiency, Claim Return LLC aims to maximize refunds while minimizing the hassle for their clients.
American Binary is a cybersecurity company made up of multi-disciplinary technologists, engineers, and security professionals who share a passion for solving the industry’s hardest and most impactful challenges.
Immunome is a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies. Our portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, targeted effectors, radioligand therapies and antibody drug conjugates (ADCs).
We believe that pursuing underexplored targets with appropriate drug modalities leads to transformative therapies. Our proprietary memory B cell hybridoma technology allows for the rapid screening and functional characterization of novel antibodies and targets.
Qana is a groundbreaking platform that utilizes advanced technology to improve the diagnosis and treatment of tumors.
Through its innovative approach, Qana provides healthcare professionals with comprehensive insights into tumor characteristics, enabling personalized and precise treatment plans. With its state-of-the-art tools and algorithms, Qana empowers medical teams to make informed decisions and deliver optimal care to patients battling tumors.
An Open Invitation
As we explore new territories in the realm of scientific innovation, we invite ventures, regardless of size or structure, to partner with us. In HEST, every bold idea gets an opportunity to see the light of day. Embark on a path of pioneering success – connect with HEST, transform vision into reality.
